Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Choosing the right retirement plan is vital for meeting your financial goals. Explore various plans to find the best fit for you.
25,593 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
DoorDash has shown impressive revenue gains, but a rising price tag isn’t a guarantee of long-term value. This guide ...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
A niche tech stock tied to crypto and forecasting markets surged today, driven by fresh funding and upbeat sentiment ...
As Heico reports Q2 2026 results, investors want to know if margins hold and growth remains intact. This article brea...
NVIDIA has moved beyond gaming GPUs to become a cornerstone of the AI era. This shift, described by some as NVIDIA ju...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...
Investors are weighing a mid-year drop in Booking Holdings against solid fundamentals. This guide explains how to ass...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
SpaceX joined the Nasdaq-100 with high expectations, but the first day brought a meaningful pullback. This guide brea...
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...